From: Impact of modern chemotherapy on the survival of women presenting with de novo metastatic breast cancer
Category A
Category B
5-Fluorouracil
Capecitabine
Epirubicin
Docetaxel
Doxorubicin
Gemcitabine
Cyclophosphamide
Ixabepilone
Etoposide
Liposomal doxorubicin
Ifosfamide
Nab-paclitaxel
Methotrexate
Paclitaxel
Cisplatin
Vinorelbine
Carboplatin